Original contributionInvestigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging
Introduction
Prostate cancer (PCa) is the fifth most common cancer worldwide and causes 6% of cancer deaths in men [1]. Transrectal ultrasonography (TRUS)-guided prostate biopsy [2] is accepted as the gold standard for diagnosis; however, the tumor detection rate remains unsatisfactory [3], and the procedure may furthermore be unpleasant to the patient.
As an alternative, magnetic resonance imaging (MRI) is showing promise for PCa localization. Generally, T2-weighted anatomical images of the gland are used to detect and stage PCa. However, this method lacks specificity (<27%) in small tumors (<1 cm in diameter) [4] and cannot distinguish between PCa and other lesions like prostatitis [5] and benign prostatic hyperplasia (BPH) [6]. To overcome these drawbacks, several other MR methods have been proposed [7], [8], [9], [10], among them diffusion-weighted imaging (DWI). The apparent diffusion coefficient (ADC) — a parameter derived from diffusion-weighted images assuming a monoexponential model — reflects the incoherent motion of tissue water at the micron scale and is hence sensitive to pathophysiological changes on the cellular level. As reported by several groups, the additional use of the ADC (which is significantly decreased in PCa compared to healthy tissue) allows for an improvement of the tumor detection rate in comparison to T2-weighted imaging alone [11], [12]. However, when using strong diffusion weightings (b values up to 3000 s/mm2), the signal decay curve was shown to be better described by a biexponential fit both in the healthy prostate [13] and PCa [14], suggesting the existence of a slow and a fast diffusing water pool owing to cellular restrictions. The intravoxel incoherent motion (IVIM) model predicts a third, much faster diffusing exponential component in the signal equation due to perfusion effects, which affects the overall signal predominantly at low b values [15]. In several abdominal organs like the liver and the pancreas, this perfusion component was recently observed and successfully described by the IVIM theory [16], [17]. The additional information due to separation of “pure” molecular diffusion and perfusion effects allowed for a better characterization of lesions than the ADC.
The purpose of this study was to determine whether IVIM imaging can play a role in differentiating between healthy and malignant prostatic tissue.
Section snippets
Basics of DWI
The term “diffusion” denotes the phenomenon of randomly oriented translation of particles caused by thermal energy (Brownian molecular motion). The self-diffusion of water molecules in the presence of magnetic field gradients leads to a signal loss in MRI measurements that in the case of free diffusion (isotropic, unrestricted diffusion) can be described by a monoexponential function [18]
Here, S is the measured signal intensity, S0 is the signal intensity without the influence of
Patients
In this study, clinical and imaging data of 13 patients (age 59–75 years; mean age 67 years) with biopsy-proven PCa were retrospectively evaluated, and informed consent was obtained from all patients. Besides T2-weighted MRI and DWI, all patients underwent prostatectomy (within 24 h after MR examination). All tumors were located in the peripheral zone (PZ). The mean prostate-specific antigen (PSA) level in these 13 patients was 10.4 ng/ml (range 2.8–21.5 ng/ml), the mean postoperative Gleason
Results
Table 1 summarizes the results obtained from ROIs in PCa and contralateral healthy tissue in all 13 patients. Along with the ADC, the IVIM parameters f and D turned out to be significantly decreased in PCa compared to healthy tissue, whereas no significant difference could be found for D⁎.
In Fig. 1, representative maps for one single patient are presented as an example. Fig. 1 (A) shows a T2-weighted anatomical image of the prostate in the traverse plane, and Fig. 1 (B) shows the image of the
Discussion
In agreement with the findings of several other groups [20], [21], [22], the ADC determined in this study was significantly decreased in PCa compared to healthy prostate tissue. However, upon closer inspection, the signal decay measured with the diffusion-sensitized sequence turned out to be clearly nonmonoexponential at the b value range used. This observation confirms the results of the prostate study by Riches et al. [23], according to which the signal could be better described by two
Conclusion
In conclusion, our results confirm that the signal decay observed within a b value range of [0–800 s/mm2] can be described well by the biexponential IVIM model, which allows for a completely noninvasive measurement of perfusion-related parameters. The significant reduction of the parameters D and f in PCa compared to healthy prostate tissue suggests that the well-known decrease of the ADC stems not only from changes in cellularity but also from perfusion effects. In both the D and the f map PCa
References (34)
- et al.
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
J Urol
(1989) - et al.
An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer
Eur Urol
(2004) - et al.
Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer
Urology
(2004) - et al.
Granulomatous prostatitis: a pitfall in endorectal MR imaging and 3D MR spectroscopic imaging
Eur J Radiol Extra
(2005) - et al.
Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range
Magn Reson Imaging
(2006) - et al.
Biexponential apparent diffusion coefficients in prostate cancer
Magn Reson Imaging
(2009) - et al.
Diffusion-weighted MRI in prostate cancer — comparison between single-shot fast spin echo and echo planar imaging sequences
Magn Reson Imaging
(2008) Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography
J Urol
(1992)- et al.
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Int J Cancer
(2010) - et al.
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy
Radiographics
(2004)
Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging
J Comput Assist Tomogr
Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence
Invest Radiol
Magnetic resonance imaging and spectroscopy of prostate cancer
Rev Urol
Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues
Magn Reson Med
Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection
Acta Radiol
Diffusion-weighted imaging of prostate cancer
J Comput Assist Tomogr
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging
Radiology
Cited by (103)
Magnetic Resonance Perfusion Imaging of Prostate
2024, Magnetic Resonance Imaging Clinics of North AmericaDiagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population
2019, European Journal of Radiology